Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study

Briot C.; Faure P.; Parmentier A. L.; Nachury M.; Trang C.; Viennot S.; Altwegg R.; Bulois P.; Thomassin L.; Serrero M.; Ah-Soune P.; Gilletta C.; Plastaras L.; Simon M.; Dray X.; Caillo L.; Del Tedesco E.; Abitbol V.; Zallot C.; Degand T.; Rossi V.; Bonnaud G.; Colin D.; Morel B.; Winkfield B.; Danset J. B.; Filippi J.; Amiot A.; Attar A.; Levy J.; Peyrin-Biroulet L.; Vuitton L.; Boureille Arnaud; Blain Antoine; Gay Claire; Koch Stephane; Ambregna Sylvain; Vaurie Fanny; Francois Stephanie; Martin Berenger; Agouzal Khadija; Boivineau Lucile; Branche Julien; Gerard Romain; Benezech Alban; Aider Belinda; Rouillon Clea; Perrod Guillaume; De Montigny Stephanie; Aygalenq Philippe

首页> 外文期刊>Journal of Crohn’s & colitis >Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study

【24h】

Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study

机译：低血液肠疾病患者的疗效，耐受性和安全性和安全性：法国多期面清洁研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Standard high-volume polyethylene glycol [PEG] bowel preparations [PEG-4L] are recommended for patients with inflammatory bowel disease [IBD] undergoing colonoscopy. However, low-volume preparations [<= 2 L of active volume] are often used in clinical practice. The aim of this study was to evaluate the efficacy, tolerability, and safety of the various bowel preparations for patients with IBD, including low-volume preparations.

机译：背景：对于接受结肠镜检查的炎症性肠病患者，建议使用标准的大容量聚乙二醇（PEG）肠道制剂（PEG-4L）。然而，临床实践中经常使用低容量制剂[<=2 L有效容量]。本研究的目的是评估各种肠道制剂对IBD患者的疗效、耐受性和安全性，包括低容量制剂。

著录项

来源
《Journal of Crohn’s & colitis》 |2019年第9期|共10页
作者
Briot C.; Faure P.; Parmentier A. L.; Nachury M.; Trang C.; Viennot S.; Altwegg R.; Bulois P.; Thomassin L.; Serrero M.; Ah-Soune P.; Gilletta C.; Plastaras L.; Simon M.; Dray X.; Caillo L.; Del Tedesco E.; Abitbol V.; Zallot C.; Degand T.; Rossi V.; Bonnaud G.; Colin D.; Morel B.; Winkfield B.; Danset J. B.; Filippi J.; Amiot A.; Attar A.; Levy J.; Peyrin-Biroulet L.; Vuitton L.; Boureille Arnaud; Blain Antoine; Gay Claire; Koch Stephane; Ambregna Sylvain; Vaurie Fanny; Francois Stephanie; Martin Berenger; Agouzal Khadija; Boivineau Lucile; Branche Julien; Gerard Romain; Benezech Alban; Aider Belinda; Rouillon Clea; Perrod Guillaume; De Montigny Stephanie; Aygalenq Philippe;
展开▼
作者单位

Univ Bourgogne Franche Comte Univ Hosp Besancon Dept Gastroenterol 3 Blvd Alexandre Fleming F;

Clin Pasteur Dept Gastroenterol Toulouse France;

Univ Hosp Besancon Ctr Methodol Clin Besancon France;

Univ Hosp Lille Gastroenterol Dept Lille France;

Univ Hosp Hotel Dieu Dept Gastroenterol &

Hepatol Nantes France;

Univ Hosp Caen Dept Gastroenterol Caen France;

Univ Hosp St Eloi Dept Gastroenterol &

Hepatol Montpellier France;

Hop Prive Louviere Ramsay Gen Sante Dept Gastroenterol Lille France;

Univ Hosp Charles Nicolle Dept Gastroenterol Rouen France;

Hop Nord Marseille AP HM Dept Gastroenterol Marseille France;

Toulon La Seyne sur Mer Hosp Dept Gastroenterol &

Hepatol Toulon France;

Univ Hosp Rangueuil Dept Gastroenterol Toulouse France;

Hosp Pasteur Dept Hepatogastroenterol Colmar France;

Inst Mutualiste Montsouris Dept Gastroenterol Paris France;

Sorbonne Univ Dept Gastroenterol Paris France;

Univ Hosp Caremeau Dept Gastroenterol &

Hepatol Nimes France;

Univ Hosp St Etienne Dept Gastroenterol St Priest En Jarez France;

Univ Hosp Cochin Dept Gastroenterol Paris France;

Lorraine Univ Univ Hosp Nancy INSERM Dept Gastroenterol U954 Nancy France;

Univ Hosp Le Bocage Dept Gastroenterol Dijon France;

Hosp Haut Anjou Dept Gastroenterol Chateau Gontier France;

Clin Ambroise Pare Toulouse France;

Clin Miotte Dept Gastroenterol F-90000 Belfort France;

Ctr Hosp Villefranche sur Saone Dept Gastroenterol Gleize France;

Hop Nord Franche Comte Dept Gastroenterol &

Hepatol Trevenans France;

Hop Europeen Georges Pompidou AP HP Dept Hepatogastroenterol Paris France;

Univ Hosp Archet Dept Gastroenterol Nice France;

Henri Mondor Hosp AP HP Dept Gastroenterol Creteil France;

Beaujon Univ Hosp Dept Gastroenterol Clichy France;

Clin Cedres Dept Gastroenterol Cornebarrieu France;

Lorraine Univ Univ Hosp Nancy INSERM Dept Gastroenterol U954 Nancy France;

Univ Bourgogne Franche Comte Univ Hosp Besancon Dept Gastroenterol 3 Blvd Alexandre Fleming F;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类杆菌传染病;
关键词
Inflammatory bowel disease IBD; colonoscopy; bowel preparations;

机译：炎症性肠病[IBD];结肠镜检查;肠道制剂;
入库时间 2022-08-20 19:50:33

相似文献

外文文献
中文文献
专利

1. Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases [J] . Neri Benedetto, Scarozza Patrizio, Giannarelli Diana, European journal of gastroenterology and hepatology . 2021,第7期

机译：炎症性肠疾病患者中非常低容量肠道制剂的功效和耐受性
2. Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases [J] . Neri Benedetto, Scarozza Patrizio, Giannarelli Diana, European journal of gastroenterology and hepatology . 2021,第2期

机译：炎症性肠疾病患者中非常低容量肠道制剂的功效和耐受性
3. Comparison of Bowel Cleansing Efficacy, Safety, Bowel Movement Kinetics, and Patient Tolerability of Same-Day and Split-Dose Bowel Preparation Using 4 L of Polyethylene Glycol: A Prospective Randomized Study [J] . Seo Myeongsook, Gweon Tae-Geun, Huh Cheal Wung, Diseases of the Colon and Rectum . 2019,第12期

机译：使用4L聚乙二醇的肠道清洁功效，安全性，肠道运动动力学和患者可耐受性的比较：使用4L聚乙二醇：预随机化研究
4. Efficacy and limits of immunomodulators in inflammatory bowel disease: azathioprine, 6-mercaptopurine, methotrexate and mycophenolate mofetil [C] . M. A. GASSULL, E. CABRE, E. DOMENECH Falk Symposium . 2004

机译：免疫调节剂在炎症性肠病中的疗效和限制：AzathioPrine，6-巯基嘌呤，甲氨蝶呤和霉酚酸酯Mofetil
5. The Effect of Bowel Preparations on the Bacterial Flora of the Colon in Healthy Subjects and in Patients with Inflammatory Bowel Disease [D] . Shobar, Rima M. 2012

机译：肠道制剂对健康受试者中结肠菌细菌植物菌的影响和炎症性肠病患者
6. Efficacy safety and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III assessor-blinded study [O] . Lawrence Hookey, Gerald Bertiger, Kenneth Lee Johnson, 2020

机译：超重和肥胖成年人中即饮型肠道制剂的功效安全性和耐受性：评估者盲研究的III期体重指数亚分析
7. P182 Bowel Preparation in inflammatory bowel diseases (IBD): preliminary results from a randomised trial evaluating efficacy, tolerability and safety of cleansing solutions in IBD patients [O] . J L Rueda Garcia, C Suárez Ferrer, E Martín-Arranz, 2020

机译：P182炎症性肠病的肠道制剂（IBD）：IBD患者中可随机试验评估疗效，耐受性和安全性的初步结果
8. Progression of Inflammatory Bowel Disease to Cancer: Is the Patient Better Off without Lymphatic Vessels or Nodes (or Angiopoietin 2) [R] . Witte, M H 2013

机译：炎症性肠病进展为癌症：如果没有淋巴管或淋巴结（或促血管生成素2），患者会更好吗？

Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study

摘要

著录项

相似文献

相关主题

期刊订阅